Inactive Instrument

Company Elite Pharmaceuticals Inc OTC Bulletin Board

Equities

US28659T2006

Pharmaceuticals

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Elite Pharmaceuticals Inc

Business Summary

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and distributes niche generic products. The Company specializes in developing and manufacturing oral, controlled-release drug products. It owns multiple generic products which has been licensed to Prasco, LLC and TAGI Pharma. The Company’s segments include Abbreviated New Drug Applications (ANDA) and New Drug Application (NDA). The Company’s products include Phentermine HCl 37.5mg tablets, Loxapine Succinate 5mg, 10mg, 25mg and 50gm capsules, Phentermine HCl 15mg and 30mg capsules, Naltrexone HCl 50mg tablets, Dantrolene Sodium Capsules 25mg, 50mg and 100mg, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Immediate Release 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 20mg and 30mg tablets, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended Release 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg capsules and others.

Sales per Business

USD in Million2023Weight2024Weight Delta
Abbreviated New Drug Applications
100.0 %
34 100.0 % 57 100.0 % +65.79%

Sales per region

USD in Million2023Weight2024Weight Delta
United States
100.0 %
34 100.0 % 57 100.0 % +65.79%

Managers

Managers TitleAgeSince
Chief Executive Officer 63 13-07-31
Chief Executive Officer 69 02-10-31
Director of Finance/CFO 59 09-06-30
Chief Operating Officer 61 13-08-11
Investor Relations Contact - 02-12-31
Corporate Officer/Principal 56 22-09-05
General Counsel - 14-10-19

Members of the board

Members of the board TitleAgeSince
Director/Board Member 68 09-10-22
Director/Board Member 93 05-03-31
Director/Board Member 76 16-04-27
Chief Executive Officer 63 13-07-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,068,373,108 781,612,414 ( 73.16 %) 100,000 ( 0.009360 %) 73.16 %

Shareholders

NameEquities%Valuation
221,572,397 21.77 % 44 M $
Carter Ward
0.4903 %
4,990,445 0.4903 % 993 099 $
Barry Dash
0.3179 %
3,235,555 0.3179 % 643 875 $
3,187,020 0.3131 % 634 217 $
2,049,436 0.2014 % 407 838 $
1,133,932 0.1114 % 225 652 $

Company contact information

Elite Pharmaceuticals, Inc.

165 Ludlow Avenue

07647, Northvale

+

http://www.elitepharma.com
address Elite Pharmaceuticals Inc
  1. Stock Market
  2. Equities
  3. ELTP Stock
  4. Stock
  5. Company Elite Pharmaceuticals Inc